27
DAFTAR PUSTAKA
Abboud IA. Mineralogy and chemistry of urinary stones : patients from north Jordan. Environ Geochem Health (2008) 30:445-463
Aggarwal KP, Shifa N, Monica K, Chanderdeep T. 2013.Nephrolithiasis: Molecular Mechanism of Renal Stone Formation and the Critical Role Played by Modulators.Uttrakhand, India.
Alaya, A, Nouri, A, Najjar, MF. 2010. Changes in stone composition according to age and gender in Tunisian children. Journal of Pediatric Urology (2010) 6, 364-371.
Baker K, Costabile RA. Demographics, stone characteristic, and treatment of urinary calculi at the 47th Combat Support Hospital during the first 6 months of Operation Iraqi Freedom. Mil Med. 2007;172(5):498-503.
Basavaraj DR, Biyani CS, Browning AJ, Cartledge JJ. 2007. The Role of Urinary Kidney Stone Inhibitors and Promoters in the Pathogenesis of Calcium Containing Renal Stones. United Kingdom.
Baumann JM, Affolter B, Casella R. 2011. Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls. Urol Res (2011) 39:421-427.
Brikowski TH, Yair L, Margaret SP. 2007. Climate-Related Increase in the Prevalence of Urolithiasis in the United States. Texas, Dallas.
Brzica H, Breljak D, Burckhardt C, Burckhardt G, Sabolic I. Oxalate from the environment to kidney stones. Brzica H, et al. oxalate urolithiasis. Arh Hig Rada Toksikol 2013;64:609-630
Childs MA, Mynderse LA, Rangel LJ, Wilson TM, Lingeman JE, Krambeck AE. 2013. Pathogenesis of Bladder Calculi in the Presence of Urinary Stasis. The Journal of Urology: Vol.189, 1347-1361.
Coe FL, Andrew E, Elaine W. 2014. Kidney Stone Disease. Illinois, USA.
28
Evan AP. 2010. Physiology and Etiology of Stone Formation in the Kidney and the Urinary Tract.PediatrNephrol 25:831-841.
Fink. Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies. 2013
Flagg RL. 2007. Dietary and Holistic Treatment of Recurrent Calcium Oxalate Kidney Stones: Review of Literature to Guide Patient Education. Urologic Nursing [1053-816X] Flagg, Laura R yr:2007 vol:27 iss:2 pg:113 -22, 143; quiz 123.
Glenn S, B C. Campbell-Wals Urology: Evaluation of the Urologic Patients: Hystory, Physical Examination, and Urinalysis. 10th ed. United States of America: Elsevier; 2012. 73-98 p.
Grases F, Costa-Bauza A, Gomila I, Ramis M, Garcia-Raja A, Prieto M. Urinary PH and renal lithiasis. Urol Res. 2012 40:41-46)
Herlitz, LC, et al. 2012. Crystalline Nephropathies. Arch Pathol Lab Med-Vol 136.
Hong YH, Dublin N, Razack AH, Mohd MA, Husain R. Urinary metabolic evaluation of stone formers-a Malaysian perspective. Urology. 2012;80(3):529-34.
Ikatan Ahli Urologi Indonesia. 2007 IAUI . Guidelines Penatalaksaan Batu Saluran Kemih . 2007
Lieske JC, Pena de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69(4):760-4.
López M, Bern H. 2010.History, Epidemiology and Regional Diversities of Urolithiasis.PediatrNephrol 25: 49-59.
Luciano LR, Perazella MA, Crystalline-induced Kidney deisease : a case for urinary microscopic.Clin Kidney J (2014) 0: 1–6
29
Margaret S, L Y. Campbell-Wals Urology: Urinary Lithiasis: Etiology, Epidemiology, and Pathogenesis. United States of America: Elsavier; 2012. 1257-86 p.
Marickar YM, Lekshmi PR, Varma L. 2009. Element distribution analysis of urinary crystals. Urol Res (2009) 37:277-282.
Marickar YM, Salim A. 2009. Clinical risk index in urolothiasis. Urol Res (2009) 37:283-287.
Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006;367(9507):333-44.
Pearle MS, Yair L. 2012. Urology Tenth Edition. Campbell-Walsh. Elsevier, p1260.
Qiu,SR, Wierzbicki A, Orme CA, Cody AM, Hoyer JR, Nancollas GH, Zepeda S, De Yoreo JJ. 2003. Molecular modulation of calcium oxalate crystallization by osteopontin and citrate. California.
Robertson WG. 2004. Kidney models of cakcium oxalate formation. Nephron Physiol 2004; 98:p21-30.
Seema L, Jawalekar, Vasant T, B A. Urinary Citrate excretion in patients with Urolithiasis. ScienSage: Journal of Advanced Scientific Research. 2013:34-7.
Shaafie IA, Sreedharan J, Muttappallymyalil J, Venkatramana M, Freeg MAHA, Mathew E. 2012. Effect of urinary pH and specific gravity in urolithiasis, Ajman, UEA. Gulf Medical Journal 2012;1(1): 26-31
Sikora P, Zajackowsaka M, Hoppe B. Assement of crystallization risk formulas in pediatric calcium stone-formers. Pediatr Nephro. 2009. 1997-2003
Strasinger, SK, Marjorie SDL. 2008. Urinalysis and Body Fluid. Fifth Edition. Philadephia, USA.
Tanagho EA, McAninch, JW. Smith’s General Urology 17th
edition. 2006
Tiselius HG. Epidemiology and medical management of stone disease. BJU Int. 2003;91(8):758-67.
Tiselius, HG. 2013. The role of calcium phosphate in the development of
30
Van Noord, C, Wulkan RW, van den Dorpel MA. 2012. Crystaluria. Netherland. Wu W, Yang D, Tiselius HG, Ou L, Liang Y, Zhu H, et al. The characteristics of
